Prescribing Pathways to Triple Therapy: A Retrospective Observational Study of Adults with Chronic Obstructive Pulmonary Disease in the UK

Dec-20

AUTHORS : Claudia Cabrera, BioPharmaceuticals Medical, AstraZeneca, Pepparedsleden 1, SE-431 83 Mölndal, Gothenburg, Sweden – Email: claudia.s.cabrera@astrazeneca.com

JOURNAL : International Journal of Chronic Obstructive Pulmonary Disease

REFERENCE: 15:3261-3271

DOI : 10.2147/COPD.S278101

Prescribing Pathways to Triple Therapy: A Retrospective Observational Study of Adults with Chronic Obstructive Pulmonary Disease in the UK

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study